NCT06329375 Food Insecurity Reduction & Strategy Team
| NCT ID | NCT06329375 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Diabetes Mellitus, Type 2 |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-10-07 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2024-10-07 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to address the multifaceted challenges posed by food disparities and their negative consequences on health outcomes, via a comprehensive community health intervention program. Study objectives include: 1. To describe the social-demographic and clinical factors associated with food insecurity in the hospitalized diabetic population. 2. To design, implement and evaluate a nutrition program targeting the hospitalized diabetic population. The investigators will prospectively randomize the target population into either a nutrition program (Intervention), or state-of-art standard of care (SOC) in a 4:1 ratio. Participants in the intervention group will be provided the following two resources in addition to SOC: 1) Enhanced access to nutritious food (twice daily meal delivery up to 90 days post-discharge) 2) Education at discharge and continuing outreach to enhance knowledge for better diet and food options. 3. To enhance community engagement and develop a systematic implementation plan for long-term roll-out of the nutrition program.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Type 1 or Type 2 Diabetes Mellitus * Admitted to Stanford Healthcare inpatient unit * Residence in California at time of enrollment * Positive Screening for Food Insecurity * On a Healthcare Plan covered by Mom's Meals. Exclusion Criteria: * Plans to be discharged to a skilled nursing facility. * Patients who prefer a language for which a short-form consent is not available. * No Home Address * Pregnant Participants. * No access to refrigerator.
Contact & Investigator
Neera Ahuja, MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT06329375 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes Mellitus, Type 2. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06329375 currently recruiting?
Yes, NCT06329375 is actively recruiting participants. Contact the research team at csantia2@stanford.edu for enrollment information.
Where is the NCT06329375 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT06329375 clinical trial?
NCT06329375 is sponsored by Stanford University. The principal investigator is Neera Ahuja, MD at Stanford University. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.